Clinical	O
correlates	O
of	O
faecal	B:C0015732
incontinence	I:C0015732
in	O
systemic	O
sclerosis	I:C0036421
:	O
identifying	O
therapeutic	O
avenues	O
.	O

Clinical	O
correlates	O
of	O
faecal	O
incontinence	I:C0015732
in	O
systemic	B:C0036421
sclerosis	I:C0036421
:	O
identifying	O
therapeutic	O
avenues	O
.	O

The	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	B:C0015732
incontinence	I:C0015732
(	O
faecal	O
incontinence	I:C0015732
)	O
in	O
SSc	O
,	O
its	O
association	O
with	O
other	O
intestinal	O
manifestations	O
and	O
potential	O
predictors	O
of	O
faecal	O
incontinence	I:C0015732
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O

The	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	O
incontinence	I:C0015732
(	O
faecal	B:C0015732
incontinence	I:C0015732
)	O
in	O
SSc	O
,	O
its	O
association	O
with	O
other	O
intestinal	O
manifestations	O
and	O
potential	O
predictors	O
of	O
faecal	O
incontinence	I:C0015732
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O

The	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	O
incontinence	I:C0015732
(	O
faecal	O
incontinence	I:C0015732
)	O
in	O
SSc	B:C0036421
,	O
its	O
association	O
with	O
other	O
intestinal	O
manifestations	O
and	O
potential	O
predictors	O
of	O
faecal	O
incontinence	I:C0015732
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O

The	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	O
incontinence	I:C0015732
(	O
faecal	O
incontinence	I:C0015732
)	O
in	O
SSc	O
,	O
its	O
association	O
with	O
other	O
intestinal	B:C0021853
manifestations	O
and	O
potential	O
predictors	O
of	O
faecal	O
incontinence	I:C0015732
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O

The	O
aim	O
was	O
to	O
establish	O
the	O
prevalence	O
and	O
severity	O
of	O
faecal	O
incontinence	I:C0015732
(	O
faecal	O
incontinence	I:C0015732
)	O
in	O
SSc	O
,	O
its	O
association	O
with	O
other	O
intestinal	O
manifestations	O
and	O
potential	O
predictors	O
of	O
faecal	B:C0015732
incontinence	I:C0015732
,	O
and	O
its	O
impact	O
on	O
quality	O
of	O
life	O
.	O

A	O
multicentre	O
,	O
cross-sectional	B:C0010362
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	B:C0036421
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	B:C1708333
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	B:C0599755
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	B:C0034394
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	B:C0349674
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	B:C0015732
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	B:C0681887
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	B:C4084861
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	B:C0426740
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	B:C0015732
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

A	O
multicentre	O
,	O
cross-sectional	O
study	I:C0010362
of	O
298	O
SSc	O
subjects	O
followed	O
in	O
the	O
Canadian	O
Scleroderma	I:C1708333
Research	I:C1708333
Group	I:C1708333
cohort	O
was	O
performed	O
using	O
validated	O
questionnaires	O
:	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
(	O
an	O
faecal	O
incontinence	I:C0015732
severity	O
scale	I:C0681887
)	O
,	O
Bristol	O
stool	I:C4084861
scale	I:C4084861
(	O
a	O
visual	O
scale	O
of	O
stool	O
consistency	I:C0426740
)	O
and	O
faecal	O
incontinence	I:C0015732
Quality	B:C0451401
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
.	O

Constipation	B:C0009806
was	O
defined	O
by	O
the	O
Rome	O
III	I:C0679228
criteria	I:C0679228
.	O

Constipation	O
was	O
defined	O
by	O
the	O
Rome	B:C0679228
III	I:C0679228
criteria	I:C0679228
.	O

Associations	O
between	O
the	O
Jorge	B:C0349674
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
and	O
other	O
clinical	O
variables	I:C1836458
were	O
determined	O
using	O
multivariate	O
regression	I:C0034980
analyses	I:C0034980
.	O

Associations	O
between	O
the	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
and	O
other	O
clinical	B:C1836458
variables	I:C1836458
were	O
determined	O
using	O
multivariate	O
regression	I:C0034980
analyses	I:C0034980
.	O

Associations	O
between	O
the	O
Jorge	O
-	I:C0349674
Wexner	I:C0349674
score	I:C0349674
and	O
other	O
clinical	O
variables	I:C1836458
were	O
determined	O
using	O
multivariate	B:C0034980
regression	I:C0034980
analyses	I:C0034980
.	O

Eighty	O
-	O
one	O
(	O
27.2	O
%	O
)	O
subjects	O
had	O
faecal	B:C0015732
incontinence	I:C0015732
,	O
which	O
was	O
mild	O
in	O
37	O
(	O
12.4	O
%	O
)	O
and	O
moderate	O
to	O
severe	O
in	O
44	O
(	O
14.8	O
%	O
)	O
.	O

Most	O
patients	O
had	O
well	O
-	O
formed	O
stools	B:C0015733
,	O
111	O
(	O
38.8	O
%	O
)	O
reported	O
constipation	O
and	O
38	O
(	O
13.4	O
%	O
)	O
had	O
been	O
previously	O
treated	O
for	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
)	O
.	O

Most	O
patients	O
had	O
well	O
-	O
formed	O
stools	O
,	O
111	O
(	O
38.8	O
%	O
)	O
reported	O
constipation	B:C0009806
and	O
38	O
(	O
13.4	O
%	O
)	O
had	O
been	O
previously	O
treated	O
for	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
)	O
.	O

Most	O
patients	O
had	O
well	O
-	O
formed	O
stools	O
,	O
111	O
(	O
38.8	O
%	O
)	O
reported	O
constipation	O
and	O
38	O
(	O
13.4	O
%	O
)	O
had	O
been	O
previously	O
treated	O
for	O
small	B:C3160854
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
)	O
.	O

Most	O
patients	O
had	O
well	O
-	O
formed	O
stools	O
,	O
111	O
(	O
38.8	O
%	O
)	O
reported	O
constipation	O
and	O
38	O
(	O
13.4	O
%	O
)	O
had	O
been	O
previously	O
treated	O
for	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
small	B:C3160854
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	B:C0015732
incontinence	I:C0015732
were	O
:	O
loose	O
vs	O
well	O
-	O
formed	O
stools	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	O
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	O
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
were	O
:	O
loose	B:C2129214
vs	O
well	O
-	O
formed	O
stools	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	O
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	O
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
were	O
:	O
loose	O
vs	O
well	O
-	O
formed	O
stools	B:C0015733
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	O
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	O
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
were	O
:	O
loose	O
vs	O
well	O
-	O
formed	O
stools	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	B:C0009806
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	O
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
were	O
:	O
loose	O
vs	O
well	O
-	O
formed	O
stools	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	O
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	B:C3160854
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	O
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Variables	O
independently	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
were	O
:	O
loose	O
vs	O
well	O
-	O
formed	O
stools	O
[	O
odds	O
ratio	O
(	O
OR	O
)	O
=	O
7.01	O
,	O
95	O
%	O
CI	O
:	O
2.09	O
,	O
23.51	O
)	O
]	O
,	O
constipation	O
(	O
OR	O
=	O
3.64	O
,	O
95	O
%	O
CI	O
:	O
1.61	O
,	O
8.27	O
,	O
P	O
=	O
0.002	O
)	O
,	O
history	O
of	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
(	O
OR	O
=	O
2.97	O
,	O
95	O
%	O
CI	O
:	O
1.06	O
,	O
8.27	O
)	O
and	O
urinary	B:C0042024
incontinence	I:C0042024
(	O
OR	O
=	O
2.45	O
,	O
95	O
%	O
CI	O
:	O
1.14	O
,	O
5.27	O
)	O
.	O

Quality	O
of	O
life	O
measured	O
with	O
the	O
faecal	B:C0015732
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
was	O
inversely	O
correlated	O
with	O
faecal	O
incontinence	I:C0015732
severity	O
(	O
correlation	O
coefficients	O
between	O
-	O
0.602	O
and	O
-	O
0.702	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Quality	O
of	O
life	O
measured	O
with	O
the	O
faecal	O
incontinence	I:C0015732
Quality	B:C0451401
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
was	O
inversely	O
correlated	O
with	O
faecal	O
incontinence	I:C0015732
severity	O
(	O
correlation	O
coefficients	O
between	O
-	O
0.602	O
and	O
-	O
0.702	O
,	O
P	O
<	O
0.001	O
)	O
.	O

Quality	O
of	O
life	O
measured	O
with	O
the	O
faecal	O
incontinence	I:C0015732
Quality	O
-	I:C0451401
of	I:C0451401
-	I:C0451401
Life	I:C0451401
scale	I:C0451401
was	O
inversely	O
correlated	O
with	O
faecal	B:C0015732
incontinence	I:C0015732
severity	O
(	O
correlation	O
coefficients	O
between	O
-	O
0.602	O
and	O
-	O
0.702	O
,	O
P	O
<	O
0.001	O
)	O
.	O

faecal	B:C0015732
incontinence	I:C0015732
was	O
common	O
and	O
often	O
severe	O
in	O
SSc	O
.	O

faecal	O
incontinence	I:C0015732
was	O
common	O
and	O
often	O
severe	O
in	O
SSc	B:C0036421
.	O

Loose	B:C2129214
stools	I:C2129214
,	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
,	O
constipation	O
and	O
urinary	O
incontinence	I:C0042024
were	O
strongly	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
.	O

Loose	O
stools	I:C2129214
,	O
small	B:C3160854
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
,	O
constipation	O
and	O
urinary	O
incontinence	I:C0042024
were	O
strongly	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
.	O

Loose	O
stools	I:C2129214
,	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
,	O
constipation	B:C0009806
and	O
urinary	O
incontinence	I:C0042024
were	O
strongly	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
.	O

Loose	O
stools	I:C2129214
,	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
,	O
constipation	O
and	O
urinary	B:C0042024
incontinence	I:C0042024
were	O
strongly	O
associated	O
with	O
faecal	O
incontinence	I:C0015732
.	O

Loose	O
stools	I:C2129214
,	O
small	O
intestinal	I:C3160854
bacterial	I:C3160854
overgrowth	I:C3160854
,	O
constipation	O
and	O
urinary	O
incontinence	I:C0042024
were	O
strongly	O
associated	O
with	O
faecal	B:C0015732
incontinence	I:C0015732
.	O

Other	O
than	O
targeting	O
anorectal	O
dysfunction	B:C0277785
,	O
concomitant	O
treatment	O
of	O
clinical	O
correlates	O
could	O
lead	O
to	O
improvement	O
in	O
faecal	O
incontinence	I:C0015732
and	O
quality	O
of	O
life	O
in	O
SSc	O
.	O

Other	O
than	O
targeting	O
anorectal	O
dysfunction	O
,	O
concomitant	O
treatment	B:C0087111
of	O
clinical	O
correlates	O
could	O
lead	O
to	O
improvement	O
in	O
faecal	O
incontinence	I:C0015732
and	O
quality	O
of	O
life	O
in	O
SSc	O
.	O

Other	O
than	O
targeting	O
anorectal	O
dysfunction	O
,	O
concomitant	O
treatment	O
of	O
clinical	O
correlates	O
could	O
lead	O
to	O
improvement	O
in	O
faecal	B:C0015732
incontinence	I:C0015732
and	O
quality	O
of	O
life	O
in	O
SSc	O
.	O

Other	O
than	O
targeting	O
anorectal	O
dysfunction	O
,	O
concomitant	O
treatment	O
of	O
clinical	O
correlates	O
could	O
lead	O
to	O
improvement	O
in	O
faecal	O
incontinence	I:C0015732
and	O
quality	O
of	O
life	O
in	O
SSc	B:C0036421
.	O

